1001-5213
2015 Issue 20
Exploration of hospital pharmacy tendency in future
JIAN Ling-yan;,HE Xiao-jing;
JIAN Ling-yan;,HE Xiao-jing;
..............page:1803-1806
Combination of ferulic acid and salvianolate based on pharmacokinetics of ferulic acid and salvianolic acid B in rat plasma
ZHANG Cui-ying;,ZHANG Hong;,DONG Yu;,REN Wei-guang;,CHEN Heng-wen;
ZHANG Cui-ying;,ZHANG Hong;,DONG Yu;,REN Wei-guang;,CHEN Heng-wen;
..............page:1807-1810
Determination of serotonin concentration in rat plasma by LC-MS/MS with pre-column derivatization
RAO Zhi;,QIN Hong-yan;,SHAO Yun-yun;,WU Xin-an;
RAO Zhi;,QIN Hong-yan;,SHAO Yun-yun;,WU Xin-an;
..............page:1811-1815
Pharmacokinetics and bioavailability of tilianin microemulsion in rats
YUAN Yong;,WANG Xin-chun;,CHEN Wei-jun;,HONG Ye;,CHEN Qing-wei;
YUAN Yong;,WANG Xin-chun;,CHEN Wei-jun;,HONG Ye;,CHEN Qing-wei;
..............page:1815-1819
Effects of pantoprazole on pharmacokinetics of amtolmetin guacil in rats
LIU Jin-yu;,XU Yan-jiao;,ZHANG Cheng-liang;,LI Xi-ping;,XIANG Dao-chun;,LIU Dong;
LIU Jin-yu;,XU Yan-jiao;,ZHANG Cheng-liang;,LI Xi-ping;,XIANG Dao-chun;,LIU Dong;
..............page:1819-1821
Study on preparation of oxymatrine sustained-release pellets and optimization of coating film formulation
JING Li-li;,SUN Shao-ping;,LIANG Na;
JING Li-li;,SUN Shao-ping;,LIANG Na;
..............page:1822-1825
Analysis of 3 inclusion technologies for bidens bipinnata volatile oil β-cyclodextrin by single factor analysis-Tukey method
HE Dan-hong;,HONG Qing;,YUAN Xi;,CHEN Yan;
HE Dan-hong;,HONG Qing;,YUAN Xi;,CHEN Yan;
..............page:1826-1829
Optimization of formula for isopropyl 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate dropping pills
HAN Jiao-jiao;,QU Qin;,WANG Yue-yue;,ZHENG Xiao-hui;,ZHANG Ya-jun;
HAN Jiao-jiao;,QU Qin;,WANG Yue-yue;,ZHENG Xiao-hui;,ZHANG Ya-jun;
..............page:1829-1833
Effects of sarpogrelate hydrochloride on the pharmacokinetics of metoprolol tartrate in rats
WANG Wei-mei;,GONG Ying;,HE Wen-juan;,ZHANG Huan;,DONG Wei-chong;,ZHANG Zhi-qing;
WANG Wei-mei;,GONG Ying;,HE Wen-juan;,ZHANG Huan;,DONG Wei-chong;,ZHANG Zhi-qing;
..............page:1833-1836
Analysis of volatile oil of ‘ underground part' of Origanum vulgare L.by GC-MS
HAN Fei;,LIU You-er;,ZHAO Zhi-dong;,CHEN Qi;,YANG Ming;,SHU Ji-cheng;,XU Han-lin;
HAN Fei;,LIU You-er;,ZHAO Zhi-dong;,CHEN Qi;,YANG Ming;,SHU Ji-cheng;,XU Han-lin;
..............page:1836-1839
Effects of hypoxia environment at high altitude on serum protein-binding rate of furosemide and methazolamide in rats
ZHANG Juan-hong;,WANG Rong;,XIE Hua;,XU Li-ting;,SUN Ai-jun;,LI Wen-bin;,JIA Zheng-ping;
ZHANG Juan-hong;,WANG Rong;,XIE Hua;,XU Li-ting;,SUN Ai-jun;,LI Wen-bin;,JIA Zheng-ping;
..............page:1839-1843
Prediction of validity duration of Kangwei capsules based on immune genetic algorithm
LU Li-rong;,LI Nan-nan;,ZHOU Jin-yang;,SHI Chun-hua;
LU Li-rong;,LI Nan-nan;,ZHOU Jin-yang;,SHI Chun-hua;
..............page:1843-1846
Protective effects and mechanism of ammonium glycyrrhizinate on isoniazid induced liver injuries in rats
FANG Yan-xiang;,ZHANG Guo-qiang;,WU Xin-an;
FANG Yan-xiang;,ZHANG Guo-qiang;,WU Xin-an;
..............page:1846-1850
Preliminary study on preparation and in vitro release of neostigmine bromide multivesicular liposomes
LUO Wen;,ZHAO Chun-jing;,ZHOU Yun-li;,HE Dan;,ZHANG Jing-qing;
LUO Wen;,ZHAO Chun-jing;,ZHOU Yun-li;,HE Dan;,ZHANG Jing-qing;
..............page:1850-1855
Study on the pharmacokinetics of CDDP-PLAS in Beagle dog
DU Hui-qiang;
DU Hui-qiang;
..............page:1855-1856,1890
In vitro PK/PD study on moxifloxacin to suppress selection of staphylococcus aureus mutant
TANG Yun-xia;,LIANG Bei-bei;,WANG Rui;
TANG Yun-xia;,LIANG Bei-bei;,WANG Rui;
..............page:1857-1862
Relationship between GGH genetic polymorphisms and blood concentrations of methotrexate in patients with non-Hodgkin's malignant lymphoma
YANG Lin;,XIE Rui-xiang;,YANG Yu;,CHEN Dao-guang;,ZOU Si-ping;
YANG Lin;,XIE Rui-xiang;,YANG Yu;,CHEN Dao-guang;,ZOU Si-ping;
..............page:1862-1865
Short-term and long-term therapeutic effects of Addie injection in treatment of advanced lung cancer
ZHANG Wen-zhou;,DU Juan;
ZHANG Wen-zhou;,DU Juan;
..............page:1865-1869
Association between MTHFD1 genetic polymorphism, methotrexate plasma concentration at large dose and adverse reactions in ALL children
zhu ying ;, zheng heng ;, liu zuo ;, cao shu zuo ;, wei ying ying ;, liu dong ;, du guang ;, ding shui ping ;, lou yi ceng ;
zhu ying ;, zheng heng ;, liu zuo ;, cao shu zuo ;, wei ying ying ;, liu dong ;, du guang ;, ding shui ping ;, lou yi ceng ;
..............page:1869-1873
Effects of beraprost sodium on IL-6, TNF-α and MPO in rats with ischemia-reperfusion injury
JIA Dong;
JIA Dong;
..............page:1874-1875
Analysis of parenteral nutrition prescriptions in premature infants
XIE Juan;,HUANG Xin-yan;,XU Yin-yan;,CHEN Yan-ni;,FU Jing;,CAO Xiao-mei;,LIU Xiao-yan;
XIE Juan;,HUANG Xin-yan;,XU Yin-yan;,CHEN Yan-ni;,FU Jing;,CAO Xiao-mei;,LIU Xiao-yan;
..............page:1876-1880
..............page:1880-1882
Analysis of cardiovascular and cerebrovascular drugs in a hospital by ABC method
SUN Ke-hong;,HOU Bao-lin;,ZENG Zhao-gang;,FAN Deng-feng;,ZHOU Hai-xia;,SHI Yu-jin;
SUN Ke-hong;,HOU Bao-lin;,ZENG Zhao-gang;,FAN Deng-feng;,ZHOU Hai-xia;,SHI Yu-jin;
..............page:1883-1884
Progress in DPP-4 genomics research and clinical application of DPP-4 inhibitor
XING Xiao-min;,ZHANG Bo;,HAN Yi;,YU Wen-jun;,YAN Yan;,LI Yan;,SU Le-qun;
XING Xiao-min;,ZHANG Bo;,HAN Yi;,YU Wen-jun;,YAN Yan;,LI Yan;,SU Le-qun;
..............page:1885-1888
..............page:1889-1890
e ta pei nan zhi zuo zuo fa zuo 1 li
chen yan ;, zhu li qin ;
chen yan ;, zhu li qin ;
..............page:1889